|
|
Blood, 1 April 2007, Vol. 109, No. 7, pp. 2847-2853.
Prepublished online as a Blood First Edition Paper on November 21, 2006; DOI 10.1182/blood-2006-08-039743.
Previous Article | Next Article 
Submitted August 4, 2006
Accepted November 10, 2006
Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses
Rongqin Ren, Peter C. Charles, Chunlian Zhang, Yaxu Wu, Hong Wang, and Cam Patterson*
Carolina Cardiovascular Biology Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
Dept of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
* Corresponding author; email: cpatters{at}med.unc.edu.
The bone morphogenetic protein (BMP) family of proteins participates in regulation of angiogenesis in physiological and pathological conditions. To investigate the molecular mechanisms that contribute to BMP-dependent angiogenic signaling, we performed gene expression profiling of BMP6-treated mouse endothelial cells. We detected 77 mRNAs that were differentially regulated after BMP6 stimulation. Of these, cyclooxygenase 2 (Cox2) was among the most highly upregulated by BMP stimulation, suggesting a role for Cox2 as a downstream regulator of BMP-induced angiogenesis. Upregulation of Cox2 by BMP6 was detected at both mRNA and protein levels in endothelial cells, and BMP6 increased production of prostaglandins in a Cox2-dependent fashion. BMP6 upregulated Cox2 at the transcriptional level through upstream SMAD-binding sites in the Cox2 promoter. Pharmacologic inhibition of Cox2, but not Cox1, blocked BMP6-induced endothelial cell proliferation, migration and network assembly. BMP6-dependent microvessel outgrowth was markedly attenuated in aortic rings from Cox2-/- mice or after pharmacologic inhibition of Cox2 in aortas from wild-type mice. These results support a necessary role for Cox2 in mediating proangiogenic activities of BMP6. These data indicate that Cox2 may serve as a unifying component downstream of disparate pathways to modulate angiogenic responses in diseases in which neovascularization plays an underlying pathophysiologic role.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. P. Mitra, V. Pagliarulo, D. Yang, F. M. Waldman, R. H. Datar, D. G. Skinner, S. Groshen, and R. J. Cote
Generation of a Concise Gene Panel for Outcome Prediction in Urinary Bladder Cancer
J. Clin. Oncol.,
August 20, 2009;
27(24):
3929 - 3937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kelley, R. Ren, X. Pi, Y. Wu, I. Moreno, M. Willis, M. Moser, M. Ross, M. Podkowa, L. Attisano, et al.
A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling
J. Cell Biol.,
February 23, 2009;
184(4):
597 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Pi, R. Ren, R. Kelley, C. Zhang, M. Moser, A. B. Bohil, M. DiVito, R. E. Cheney, and C. Patterson
Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors
J. Cell Biol.,
December 31, 2007;
179(7):
1569 - 1582.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|